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Abstract
In contrast to cardiomyocytes, store overload-induced calcium ion (Ca2+)
release (SOICR) is not considered to constitute a primary Ca2+ releasing sys-
tem from the sarcoplasmic reticulum (SR) in skeletal muscle myocytes. In the
latter, voltage-induced Ca2+ release (VICR) is regarded as the dominant mech-
anism facilitating contractions. Any role of the SOICR in the regulation of
cytoplasmic Ca2+ concentration ([Ca2+]i) and its dynamics in skeletal muscle
in vivo remains poorly understood. By means of in vivo single fiber Ca2+
microinjections combined with bioimaging techniques, we tested the hypothe-
sis that the [Ca2+]i dynamics following Ca
2+ injection would be amplified and
fiber contraction facilitated by SOICR. The circulation-intact spinotrapezius
muscle of adult male Wistar rats (n = 34) was exteriorized and loaded with
Fura-2 AM to monitor [Ca2+]i dynamics. Groups of rats underwent the fol-
lowing treatments: (1) 0.02, 0.2, and 2.0 mmol/L Ca2+ injections, (2)
2.0 mmol/L Ca2+ with inhibition of ryanodine receptors (RyR) by dantrolene
sodium (DAN), and (3) 2.0 mmol/L Ca2+ with inhibition of SR Ca2+ ATPase
(SERCA) by cyclopiazonic acid (CPA). A quantity of 0.02 mmol/L Ca2+ injec-
tion yielded no detectable response, whereas peak evoked [Ca2+]i increased
9.9  1.8% above baseline for 0.2 mmol/L and 23.8  4.3% (P < 0.05) for
2.0 mmol/L Ca2+ injections. The peak [Ca2+]i in response to 2.0 mmol/L Ca
2+
injection was largely abolished by DAN and CPA (85.8%, 71.0%, respec-
tively, both P < 0.05 vs. unblocked) supporting dependence of the [Ca2+]i
dynamics on Ca2+ released by SOICR rather than injected Ca2+ itself. Thus,
this investigation demonstrates the presence of a robust SR-evoked SOICR
operant in skeletal muscle in vivo.
Introduction
Precise control of cytoplasmic calcium ion concentration
([Ca2+]i) is crucial for regulation of myocyte function
and the excitation–contraction (E–C) coupling process in
particular. In skeletal muscle myocytes, contraction and
relaxation are evoked by [Ca2+]i increase and decrease,
respectively. The primary Ca2+ releasing systems from the
sarcoplasmic reticulum (SR) are action potential-induced
calcium release (voltage-induced Ca2+ release; VICR)
(Schneider 1994; Hernandez-Ochoa et al. 2015), Ca2+-
induced Ca2+ release (CICR) (Endo 2009) and store
overload-induced Ca2+ release (SOICR) (Kong et al. 2007;
Prakriya and Lewis 2015).
The ryanodine receptor (RyR) is a Ca2+ releasing chan-
nel on the SR membrane. In mammals, three RyR iso-
forms exist (RyR1, RyR2 and RyR3) with RyR1 being
dominantly expressed in skeletal (Nakai et al. 1990; Otsu
et al. 1990; Zorzato et al. 1990) as opposed to RyR2 in
cardiac muscle (Nakai et al. 1990; Otsu et al. 1990; Zor-
zato et al. 1990). RyR3, discovered initially in the brain,
also is present in the skeletal muscle (Giannini et al.
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1995). However, RyR3 expression disappears in hind limb
muscles of adult animals (Flucher et al. 1999). RyR is
opened by interaction with the dihydropyridine receptor
(DHPR), which is the voltage-dependent Ca2+ channel of
the transverse tubule membrane (Lanner et al. 2010).
Myocardial RyR2 causes Ca2+ release by binding with the
Ca2+ which flows into the cytosol across the sarcolemma
(Fabiato 1992; Maack and O’Rourke 2007). In marked
contrast, skeletal muscle RyR1 is opened by the structural
change in the RyR1-DHPR conjugate (Beam and Bannis-
ter 2010). Because this opening occurs in the absence of
Ca2+ influx from the extracellular space, unlike that for
cardiomyocytes, it is thought that a rise in [Ca2+]i is not
necessary for RyR1-mediated SR Ca2+ release. However,
not all SR RyR1 is in contact with DHPR. Thus, the pres-
ence of non-DHPR-associated RyR1 in skeletal muscle
myocytes raises the possibility that these particular RyR10s
may release Ca2+ in a process instigated by Ca2+ that is
released from the conjugated DHPR-RyR1 (Klein and
Schneider 2006; Pouvreau et al. 2007; Van Petegem
2012).
Although SOICR is well known to operate via RyR2 in
cardiomyocytes, it has never been observed for RyR1-
bearing skeletal muscle myocytes even under conditions
propagating Ca2+release via the SR (Zhou et al. 2004; Fig-
ueroa et al. 2012). Interestingly, however, the Ca2+ sens-
ing gate on the RyR for SOICR has been identified as a
common gating structure for all RyR isoforms (Chen
et al. 2014) and Ca2+ release via SOICR does occur in
skeletal muscle myocytes similar to cardiac myocytes
expressing RyR2 (Cully et al. 2014). In addition, reduc-
tion of Ca2+ entry across the sarcolemma reduces SR
Ca2+ accumulation and induces muscle fatigue (Stiber
et al. 2008). Collectively, these findings suggest that Ca2+
release by SOICR might play an important role in skeletal
muscle in vivo.
Because RyR regulation is extremely sensitive to the
cytosolic and luminal environments, and changes thereof
(Laver et al. 2000; Fill and Coppell 2002; Capes et al.
2011), direct evidence for the presence of SOICR must be
obtained under in vivo conditions especially as regards
pH, temperature, reactive O2 species, and O2 partial pres-
sure. The present investigation was designed to resolve
the presence and putative importance of SOICR in an
in vivo skeletal muscle using Ca2+ solutions injected
directly into the myocyte cytosol which bypasses the
VICR process entirely. We hypothesized that the [Ca2+]i
change in response to the Ca2+ solution injection would
be amplified by SOICR, raising [Ca2+]i substantially and
causing muscle contraction. Furthermore, it was hypothe-
sized that this amplification would be either abolished or
reduced when Ca2+ release from the SR is inhibited,
either directly via the blockade of RyR by the hydantoin
derivative dantrolene (DAN), or indirectly via the deple-
tion of Ca2+ from the SR by inhibiting SERCA with
cyclopiazonic acid (CPA).
Methods
Animals
Male Wistar rats (n = 34, 10–14 weeks of age; Japan SLC,
Shizuoka, Japan) were used in this study. Rats were main-
tained on a 12:12-h light/dark cycle and received food
and water ad libitum. All experiments were conducted
under the guidelines established by the Physiological Soci-
ety of Japan and were approved by the University of Elec-
tro-Communications Institutional Animal Care and Use
Committee. The rats were anesthetized using pentobarbi-
tal sodium (60 mg/kg i.p.), and supplemental doses of
anesthesia were administered as needed. At the end of the
experimental protocols, animals were killed by pentobar-
bital sodium overdose.
Muscle preparation
All experimental techniques, including the spinotrapezius
muscle preparation, were performed, as described previ-
ously (Sonobe et al. 2008; Eshima et al. 2013). Briefly, the
right spinotrapezius muscle was gently exteriorized with
minimal blood loss and tissue/microcirculatory damage,
and attached to a wire horseshoe around the caudal
periphery by six equidistant sutures placed around the
muscle perimeter. The exposed muscle tissue was kept
moist by superfusing with warmed Krebs–Henseleit buffer
(KHB; 132 mmol/L NaCl, 4.7 mmol/L KCl, 21.8 mmol/L
NaHCO3, 2.0 mmol/L MgSO4, and 2.0 mmol/L CaCl2)
equilibrated with 95% N2-5% CO2 and adjusted to pH
7.4, at 37°C. The fluorescent Ca2+ indicator Fura-2 AM
(5 mmol/L; Dojindo Laboratories, Kumamoto, Japan)
was dissolved in dimethyl sulfoxide (DMSO) and Pluro-
nic F-127 and dispersed into KHB solution at a final con-
centration of 40 lmol/L. The muscles were incubated in
Fura-2 AM/KHB solution for 60 min on a 37°C hot plate
(Kitazato Supply, Shizuoka, Japan). After incubation,
muscles were rinsed with dye-free KHB solution to
remove nonloaded Fura-2 AM.
In vivo image analysis
The spinotrapezius muscles loaded with Fura-2 AM were
mounted on the 37°C glass hot plate and observed by flu-
orescence microscopy using a 10 9 objective lens (0.30
numerical aperture; Nikon, Tokyo, Japan). After ensuring
that the spinotrapezius muscle was not grossly damaged
and supported robust capillary blood flow, a sampling
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area ( 880 9 663 lm) was selected, and bright-field
images were captured. Thereafter, 340 and 380 nm wave-
length excitation light was delivered using a Xenon lamp
equipped with appropriate fluorescent filters, and pairs of
fluorescence images were captured through the 510 nm
emission wavelength filter for ratiometry (Roe et al.
1990). The fluorescence intensity of serial ratio images
was normalized to the starting point (i.e., precondition,
R0) of each experiment (R/R0).
Experimental Protocols
In vivo injection of Ca2+ solution
Capillary micropipettes were generated with a tip of 5 lm
in diameter, which was achieved by custom grinding and
inserted into the selected single muscle fiber using a
micromanipulator precision-controlled advancer (MMO-
220A; Narishige, Tokyo, Japan). Subsequently, using a
microinjector (IM300; Narishige, Tokyo, Japan), a single
muscle fiber was microinjected with 0.02, 0.2, and
2.0 mmol/L Ca2+ solution by microinjection at 35 psi
(24,000 Pa) for 1 sec ( 0.78 9 103 lL) (Tanaka et al.
2016). We used a piezoassisted micromanipulation system
for perforation of the cell membrane (PiezoXpert; Eppen-
dorf, Hamburg, Germany). The injection solution was
adjusted using a mixture of Ca2+-free solution (KCl:
145 mmol/L, NaCl: 3.5 mmol/L, MgCl2: 10 mmol/L,
NaOH: 6.5 mmol/L, HEPES: 10 mmol/L) and the Ca2+
solution (CaCl2・2H2O: 10 mmol/L). Criteria for successful
injection included an unchanged [Ca2+]i in adjacent mus-
cle fibers. Fluorescence images were captured by a high-
sensitivity CCD (charge-coupled device) digital camera
(ORCA-Flash2.8; Hamamatsu Photonics, Hamamatsu,
Japan) using image-capture software (NIS-Elements
Advanced Research; Nikon, Tokyo, Japan) for 60 sec after
injection. The scan requirements were set at 300–
800 msec/image. We confirmed that insertion of the cap-
illary micropipette itself and injection of Ca2+-free solu-
tion did not induce any [Ca2+]i change. The specific
region of interest (ROI, width: 20 lm, height: 80% of
muscle fiber diameter) for the Ca2+ measurement was set
at a distance of 40 lm from the injection point. All
experiments were performed with the rat’s body tempera-
ture maintained at 37–38°C with the exteriorized muscles
mounted on the 37°C glass hotplate.
Pharmacologic block of the SR function
Pharmacological agents DAN and CPA were purchased
from Sigma-Aldrich (St. Louis, MO). DAN inhibits single
ryanodine receptor (RyR) Ca2+ release channels (Kobaya-
shi et al. 2005; Oo et al. 2015). CPA is a highly specific
and potent SERCA inhibitor (Seidler et al. 1989). Each
inhibitor was dissolved in DMSO and diluted with KHB
(DAN: 100 and 500 lmol/L, CPA: 10, 50, and 100 lmol/
L) and the pharmacological action was confirmed by con-
structing dose–response curves. Based upon these studies,
following Fura-2 incubation and rinse, DAN (100 lmol/
L) or CPA (100 lmol/L) was applied for 5 min before
the start of experiments. Subsequently, a single muscle
fiber was microinjected with either of the 0.02, 0.2, and
2.0 mmol/L Ca2+ solution.
In vivo injection of caffeine solution
This protocol was the same as for the Ca2+ injection. The
caffeine solution (100 lmol/L) was injected into each sin-
gle muscle fiber both with and without DAN conditions.
Evaluation of the muscle fiber length
The muscle fiber shortening (i.e., contraction rate) was
calculated frame-by-frame using autologous fluorescent
landmarks, located close to the injection point and thus
~40 lm from the ROI. The resolution was 0.73 lm per
pixel.
Statistical analysis
All experimental data are expressed as means  SE. All
statistical analyses were performed in Prism version 6.0
(GraphPad Software, San Diego, CA). Comparisons
among different groups were analyzed by either one-way
or two-way ANOVA followed by Tukey’s multiple-com-
parison test. The level of significance was set at P < 0.05
(two-tailed).
Results
In contrast to the Ca2+-free and 0.02 mmol/L Ca2+ injec-
tions which caused no detectable [Ca2+]i change, 0.2 and
2.0 mmol/L injections elicited significant increases in
[Ca2+]i, indicated by 9.9  1.8% and 23.8  4.3%
increases in R/R0 within 1–2 sec after injection, respec-
tively (both P < 0.0001, two-way ANOVA, Figs. 1, 2).
Interestingly, the [Ca2+]i increase declined subsequently
but [Ca2+]i did not return to resting levels within the
60 sec observation period.
The functional concentrations of each inhibitor (DAN
and CPA) were verified under in vivo conditions
before Ca2+ injection (Fig. 3A). As evident from Fig-
ure 3B, the increment of [Ca2+]i with Ca
2+ injec-
tion was barely detectable after DAN treatment
(2.0 mmol/L: 3.4  1.2%, 0.2 mmol/L: 3.6  0.8%,
0.02 mmol/L: 1.9  0.7% vs. unblocked control). With
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CPA-induced SERCA blockade, the [Ca2+]i increase after
injection was substantially blunted compared with the
unblocked control condition (i.e., control 2.0 mmol/L
Ca2+ injection, 23.8  4.3% vs. CPA, 5.3  1.0%,
P < 0.05).
Caffeine injection induced a 13.8  2.6% [Ca2+]i
increase above baseline (Fig. 4). Unlike the 0.2 mmol/L
and 2.0 mmol/L injectates, this [Ca2+]i increase resolved
to baseline within 60 sec (compare Figs. 2, 4). DAN
blockade of RyR almost completely abolished the caf-
feine-induced [Ca2+]i increase (Fig. 4).
2.0 mmol/L Ca2+ injection induced a rapid (peak
velocity, 43.0  11.0 lm/sec) and substantial (peak short-
ening length, 89.5  15.1 lm, mean shortening length
48.0  7.7 lm) fiber shortening as seen in Figure 5.
Two-way repeated-measures analyses revealed a significant
effect for DAN (P < 0.03, vs. Ca2+ alone condition) and
CPA (P < 0.03, vs. Ca2+ alone condition) on shortening
fiber length. Specifically, the mean shortening length was
significantly reduced in both DAN (25.1  6.6 lm) and
CPA (14.4  4.0 lm) compared with 2.0 mmol/L Ca2+
alone (Fig. 5D).
For the caffeine condition, compared with the
2.0 mmol/L Ca2+ injection, there was a strong tendency
for a reduced shortening (22.9  4.6 lm, P = 0.059,
Fig. 5D) and a slower velocity of shortening
(16.3  2.5 lm/sec, P = 0.060, Fig. 5C).
Discussion
This investigation represents the first in vivo imaging of
[Ca2+]i dynamics associated with direct single fiber Ca
2+
loading in an in vivo skeletal muscle of rats. The principal
original finding was that the [Ca2+]i dynamics following
Ca2+ injection reflect Ca2+ released by SOICR rather than
the effects of the injected Ca2+ itself. This schema is sup-
ported by the almost complete abolition of [Ca2+]i
increase consequent to RyR and SERCA inhibition.
[Ca2+]i response to Ca
2+ injection
In the absence of intramyocyte (e.g., troponin) Ca2+
binding as well as SR release and sequestration processes
the change in [Ca2+]i should directly reflect the amount
After injection Pre injection (–10 sec) 5 sec 10 sec
20 sec 30 sec 60 sec
1.5
1.0
0
High [Ca2+]i
Low 
Figure 1. Representative example of changes in intracellular Ca2+ concentration ([Ca2+]i) induced by 2.0 mmol/L Ca
2+ microinjection into a
single rat spinotrapezius muscle myocyte. The injection site is shown with an arrow. The specific region of interest (width: 20 lm, height: 80%
of muscle fiber diameter) for the Ca2+ measurement was set to a distance of 40 lm from the injection point. Scale bar = 50 lm. Pseudocolor
bar indicates the 340/380-nm ratio value.
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of injected Ca2+ within the cytoplasmic distribution vol-
ume. For instance, in a myocyte that has a 60 lm diame-
ter and length 700 lm, the volume will be approximately
2.0 9 103 lL. When 0.78 9 103 lL of 0.02, 0.2, and
2.0 mmol/L Ca2+ solution was injected, it is estimated
that the [Ca2+]i will increase to 0.0057, 0.057, and
0.57 mmol/L, respectively. As can be seen from Figures 2
and 3, however, there was no proportional relationship
between injected [Ca2+] and the resultant rise in [Ca2+]i,
providing evidence for the presence of a complex Ca2+
homeostasis system. That the 0.02 mmol/L injection did
not elevate [Ca2+]i indicates that either any [Ca
2+]i
increase was below the sensitivity of our detection system
or, alternatively, the injected Ca2+ was removed by Ca2+-
troponin binding and/or sequestration processes by SR
and mitochondria. In contrast, both 0.2 mmol/L and
2.0 mmol/L injections invoked a rapid and substantial
increase in [Ca2+]i (Fig. 2) that was almost entirely pre-
vented by either RyR (DAN) or SERCA (CPA) inhibition
(Fig. 3). This observation provides strong evidence that a
functional and robust SOICR is present in rat myocytes
in vivo.
Ca2+ itself modulates RyR channel activity (Gehlert
et al. 2015) being stimulatory at low Ca2+ (~1 lmol/L)
and inhibitory at extremely high Ca2+ (~1 mmol/L)
(Meissner 1986). DAN inhibits skeletal muscle L-type
Ca2+ currents by disrupting communication between
RyR1 and Ca(V)1 which provides the only treatment for
malignant hyperthermia resulting from RyR1 mutations
(Zhao et al. 2001; Bannister 2013). Although the precise
molecular mechanism(s) for DAN’s RyR1 functional
action remain to be defined (Nelson et al. 1996; Oo et al.
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Figure 2. Influence of the different Ca2+ injections (0.02, 0.2
2.0 mmol/L) on intracellular Ca2+ concentration ([Ca2+]i) in vivo.
Fluorescence was measured continuously during the 60 sec
measurement interval and ratiometrically quantified data were
graphed as changes from precondition (i.e. 10 sec) levels (R0).
Values shown are means  SE (N = 10, 0.02 mmol/L: n = 14,
0.2 mmol/L: n = 17, 2.0 mmol/L: n = 17). N = number of animals.
n = number of muscle fibers measured. There was a significant
interaction effect for treatment condition (0.02, 0.2 and 2.0 mmol/
L) and time course of injection (P < 0.001). Significant difference
between each conditions for the same time points: *P < 0.05 (vs.
0.02 mmol/L), #P < 0.05 (vs. 2.0 mmol/L).
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Figure 3. (A) The dose–response curves show the pharmacologic function of DAN (100, 500 lmol/L) and CPA (10, 50, 100 lmol/L) in the
in vivo environment. (B) Influence of the DAN, top panel and CPA, bottom panel in vivo on intracellular Ca2+ concentration ([Ca2+]i). Values
shown are means  SE (DAN condition: N = 7, 0.02 mmol/L: n = 14, 0.2 mmol/L: n = 18, 2.0 mmol/L: n = 18, CPA condition: N = 7,
0.02 mmol/L: n = 15, 0.2 mmol/L: n = 15, 2.0 mmol/L: n = 15). N = number of animals. n = number of muscle fibers measured. CPA,
cyclopiazonic acid; DAN, dantrolene sodium.
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2015), discrete findings within isolated muscle and
skinned muscle fibers offer pertinent clues. For instance,
in E–C coupling, DAN diminishes the twitch tension
much more than the tetanic tension (Leslie and Part
1981) and both reduced temperatures (22°C) (Ohta et al.
1990; Krause et al. 2004; Kobayashi et al. 2005) and the
presence of Mg2+ (Ohta et al. 1990; Owen et al. 1997)
impair DAN’s ability to inhibit RyR1. Unfortunately, as
mentioned in the Introduction, in vitro conditions pre-
sent in those investigations are expected, in and of them-
selves, to perturb [Ca2+]i and RyR regulation. Specifically,
RyR is a redox-sensitive channel and myocyte redox regu-
lation is dependent on O2 (and thus O2 partial pressure,
PO2) (Salama et al. 2000; Powers et al. 2011). Although
physiological microvascular PO2 are 20–30 Torr in the
in vivo spinotrapezius muscle (Kano et al. 2005) and
intramyocyte PO2 must be even lower, studies of isolated
skeletal muscles are routinely performed in hyperoxic
environments (95% O2, >600 Torr). This realization tem-
pers confidence in translating ex vivo findings to the
in vivo environment. Notwithstanding this consideration,
the present investigation has extended previous observa-
tions regarding [Ca2+]i control and represents the first
investigation to provide evidence for SOICR function
in vivo.
The effects of RyR and SERCA inhibition on the
[Ca2+]i response and contractile function
We hypothesized that SOICR function would be abol-
ished when Ca2+ release from the SR is inhibited, either
directly via the blockade of RyR (DAN), or indirectly via
the depletion of Ca2+ from the SR (CPA). This hypothesis
was supported by the almost complete abolition of
[Ca2+]i increases by DAN and CPA applied separately.
SOICR has been observed in RyR2 containing car-
diomyocytes (Diaz et al. 1997; Eisner et al. 2009) and
occurs consequent to RyR opening when the stored Ca2+
content exceeds some threshold level. SOICR has been
observed for RYR1 in skeletal muscle myocytes as well as
RyR3 in smooth muscle (Chen et al. 2014). As we added
an additional Ca2+ load to the myocytes, we considered
this to be the basis for triggering SOICR. Recently, Cully
and colleague observed in rodent skinned fibers that a
local [Ca2+]i increase via SOICR was propagated by
movement of Ca2+ inside the SR (Cully et al. 2014). A
similar phenomenon was identified in rabbit ventricular
myocytes where local SR Ca2+ uptake by SERCA facili-
tated propagation of cytosolic Ca2+ waves via luminal
sensitization of the RyR (Maxwell and Blatter 2012).
These cytoplasmic Ca2+ waves can be explained by dis-
crete fluctuations of Ca2+ inside the SR network. In the
present investigation, we have demonstrated that, follow-
ing injection of 0.2 and 2.0 mmol/L Ca2+ solution, phar-
macologic inhibition of SR Ca2+ release by DAN and
uptake by CPA largely, but not totally, prevented subse-
quent [Ca2+]i increase (Fig. 3, lower panel). As injected
Ca2+ would be instantly sequestered by SERCA, when
allowed to function normally (i.e., absence of CPA) this
would acutely increase net SR Ca2+ stores. Consequently,
local Ca2+ release following Ca2+ injection would be trig-
gered by the SOICR system and contribute to the con-
tractile behavior evident in Figure 5. Interestingly, even in
the presence of DAN or CPA 40–60% of the control mus-
cle contractile response (extent of shortening and shorten-
ing velocity) was preserved. The most likely explanation
for this behavior is that the injected Ca2+ bound immedi-
ately to troponin and directly facilitated contraction.
Consideration of the experimental model
We examined Ca2+ release with caffeine to confirm the
physiological response of the in vivo experimental model.
Caffeine increases the sensitivity of RyR for Ca2+ (Rous-
seau et al. 1988; Zucchi and Ronca-Testoni 1997; Mur-
ayama et al. 2000) and caffeine-induced Ca2+ transients
are evident in myotubes and adult skeletal muscle (Endo
et al. 1970; Horiuti 1988; Lamb et al. 2001). In this study,
under the in vivo control condition, there was a signifi-
cant increase in [Ca2+]i after caffeine injection, and this
was markedly attenuated by DAN (Fig. 4). That Ca2+
release by caffeine could be inhibited by DAN provides
additional evidence that the Ca2+ release via SR is present
and functional in vivo. Also, the muscle contraction
Time (sec) 
–10 0 10 20 30 40 50 60
R
/R
0
1.3
1.2
1.0
1.1
0.9
Caffeine/DAN 
Caffeine 
* * * * *
* * *
Figure 4. Influence of caffeine injection with/without DAN in vivo
on intracellular Ca2+ concentration ([Ca2+]i). Values shown are
means  SE (caffeine condition: N = 5, n = 9, caffeine/DAN
condition: N = 5, n = 8). N = number of animals. n = number of
muscle fibers measured. There was a significant interaction effect
for treatment condition (caffeine injection with/without DAN) and
time course of injection (P < 0.001). Significant difference between
each condition at the same time point: *P < 0.05 (caffeine injection
with vs. without DAN). DAN, dantrolene sodium.
2017 | Vol. 5 | Iss. 5 | e13180
Page 6
ª 2017 The Authors. Physiological Reports published by Wiley Periodicals, Inc. on behalf of
The Physiological Society and the American Physiological Society.
Ca2+ Injection-Induced In Vivo Ca2+ Dynamics M. Wakizaka et al.
induced by caffeine injection is most likely the result of
RyR-released Ca2+. The peak shortening velocity and
extent of fiber shortening with caffeine tended to be
slower and reduced compared with the control Ca2+ con-
dition (P = 0.06, Fig. 5 panel C) which might be associ-
ated with inertia in the Ca2+ release system resulting from
caffeine-induced RyR sensitization. Under these circum-
stances, it would be expected that the SOICR Ca2+ release
rate would be far slower than VICR. However, resolution
of the mechanistic basis for this behavior will require
more precise temporal measurements of the contractile
response than attempted, or possible, herein.
The [Ca2+]i in mammalian myocyte is around 20–
50 nmol/L under resting conditions, while the peak
[Ca2+]i increases to the low lmol/L level during tetanic
stimulation (Allen and Westerblad 2001). Computational
modeling estimates that the total released SR Ca2+ is
around 0.35 mmol/L during tetanic stimulation in intact
fast-twitch mouse myocytes (Baylor and Hollingworth
2003). It is quite possible therefore that the local injection
of 2.0 mmol/L Ca2+ may be beyond the range seen physi-
ologically. Although highly concentrated Ca2+ (~1 mmol/
L) has been shown to inhibit rather than facilitate RyR
function (Meissner 1986), the present results clearly
demonstrate facilitation of RyR Ca2+ release. Therefore,
even though we elected to inject 2.0 mmol/L Ca2+ the
volume was extremely small (0.78 nL) and the resultant
free [Ca2+]i is expected to be reduced immediately by
intramyocyte buffering mechanisms and dilution within
the far larger cytosolic volume.
Mg2+, Zn2+, NO, and ATP are known modulators
of the RyR function (Xia et al. 2000; Lanner et al.
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Figure 5. (A) Changes of muscle fiber length (i.e., extent of shortening) during each injection protocol (Ca2+, Ca2++DAN, Ca2++CPA, and
caffeine). Values shown are means  SE (Ca2+: n = 12, Ca2++DAN: n = 14 Ca2++CPA: n = 15, caffeine: n = 9). n = number of muscle fibers
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2010; Suhr et al. 2013) and perturbations in the con-
centrations of these molecules, and therefore Ca2+
regulation, is inevitable when the in vivo myocyte
environment is lost. For instance, the ATP require-
ment for the SR Ca2+ pumping, required to maintain
Ca2+ homeostasis, demands up to 40–50% of resting
cellular energy consumption (Smith et al. 2013). Even
if it is possible to provide sufficient O2 in vitro to
sustain this activity disruption of the intracellular PO2
(by hyperoxia and/or hypoxia) will invariably alter
metabolic regulation, intramyocyte redox and the
intramyocyte milieu (e.g., (Hogan et al. 1992; Wilson
et al. 1977). This consideration demands careful inter-
pretation of in vitro data when applying them to
in vivo physiological mechanisms and is especially
pertinent for understanding in vivo muscle Ca2+
homeostasis. A signatory advantage of the present
investigation is having a preparation that maintains
close-to-physiological intramyocyte homeostasis espe-
cially as regards ion balance and energy supply.
In conclusion, in the absence of VICR, we demon-
strated, for the first time, evidence for SR SOICR in
in vivo single mammalian skeletal muscle myocytes. The
SOICR demonstrated induced elevated [Ca2+]i and signif-
icant myocyte shortening; both of which were diminished
substantially by RyR blockade or SERCA inhibition.
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